GLP-1 | World Briefings
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Lexaria Bioscience Appoints New CEO as Company Transitions to Focus on Pharmaceutical Industry Collaboration

Business

9 Sep, 2024

Lexaria Bioscience Appoints New CEO as Company Transitions to Focus on Pharmaceutical Industry Collaboration


Lexaria Bioscience Corp. (NASDAQ:LEXX) is embarking on a new era with a renewed focus on pharmaceutical industry collaborations and advancing...

Ozempic and Wegovy: New Study Raises Concerns About Suicidal Thoughts

World

24 Aug, 2024

Ozempic and Wegovy: New Study Raises Concerns About Suicidal Thoughts


The use of semaglutide, the popular medication for diabetes and weight loss, has surged in recent years. Sold under the...

Ozempic and Similar Weight Loss Drugs Boost Metabolism, Not Just Reduce Appetite, New Study Finds

Health

24 Aug, 2024

Ozempic and Similar Weight Loss Drugs Boost Metabolism, Not Just Reduce Appetite, New Study Finds


Weight loss drugs such as Ozempic, Wegovy and Mounjaro seem to directly impact metabolism, not just appetite, according to a...

Top Biopharma Companies Witness 4.3% Market Cap Growth in Q2 2024, GLP-1 Innovators Lead the Pack

Business

21 Aug, 2024

Top Biopharma Companies Witness 4.3% Market Cap Growth in Q2 2024, GLP-1 Innovators Lead the Pack


The global biopharmaceutical industry demonstrated resilience in the second quarter (Q2) of 2024, with the top 20 companies reporting a...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates